The Role of Peripheral Type 2 Innate Lymphoid Cells in Bronchiolitis

Overview

Journal Sci Rep

Specialty Science

Date 2021 Jan 30

PMID 33514798

Citations 2

Authors

Yong-Jun Tang

Li-Li Xie

Xiang-Rong Zheng

Chen-Tao Liu

Xia Wang

Affiliations

Soon will be listed here.

Abstract

Our aim was to detect type 2 innate lymphoid cells (ILC2s)-related cytokines of infants with bronchiolitis by using Elisa, Liquidchip technology and RT-PCR and investigated its correlation with bronchiolitis. We recruited 26 infants with bronchiolitis and 20 healthy infants as control from Xiangya Hospital. Compared to the control group, the serum levels of interleukin-5 (IL-5) [41.99 (21.11) vs 25.70 (19.64)], IL-9 [27.04 (37.51) vs 8.30 (0.54)], IL-13 [184.05 (132.81) vs 121.75 (176.13)], IL-33 [83.70 (46.69) vs 11.23 (55.31)] and thymic stromal lymphopoietin (TSLP) [31.42 (5.41) vs 28.76 (2.56)] were significantly increased in infants with bronchiolitis (P < 0.05), while the level of IgE had no significant difference between the two groups [19.05 (14.15) vs 14.85 (20.2), P > 0.05]. The mRNA expression of IL-17RB (9.83 ± 0.35 vs 9.19 ± 0.58), TSLP (16.98 ± 2.12 vs 15.07 ± 2.25), retinoid acid receptor related orphan receptor α (7.18 ± 0.71 vs 5.46 ± 1.09) and trans-acting T-cell-specific transcription factor 3 (4.86 ± 0.66 vs 4.19 ± 0.90) were significantly increased in infants with bronchiolitis versus the control group (P < 0.05), while there was no statistical significance for suppression of tumorigenicity 2 (5.59 ± 0.68 vs 5.41 ± 0.87, P > 0.05). Our findings suggested that ILC2s possibly play a specific role in immunopathology of bronchiolitis.

Citing Articles

Exposure to family and domestic violence in the prenatal period is associated with an increased risk of hospitalization for bronchiolitis in children under 2 years.

Orr C, Kelty E, Belinelo P, Fisher C, Glauert A, ODonnell M J Public Health (Oxf). 2024; 46(3):e448-e457.

PMID: 38925867 PMC: 11358643. DOI: 10.1093/pubmed/fdae120.

The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function.

Prentice R, Wright E, Flanagan E, Hunt R, Moore G, Nold-Petry C Cell Mol Gastroenterol Hepatol. 2023; 16(1):165-181.

PMID: 36972763 PMC: 10285251. DOI: 10.1016/j.jcmgh.2023.03.005.

References

Ralston S, Garber M, Rice-Conboy E, Mussman G, Shadman K, Walley S . A Multicenter Collaborative to Reduce Unnecessary Care in Inpatient Bronchiolitis. Pediatrics. 2015; 137(1). DOI: 10.1542/peds.2015-0851. View

Halim T, MacLaren A, Romanish M, Gold M, McNagny K, Takei F . Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity. 2012; 37(3):463-74. DOI: 10.1016/j.immuni.2012.06.012. View

Yanney M, Vyas H . The treatment of bronchiolitis. Arch Dis Child. 2008; 93(9):793-8. DOI: 10.1136/adc.2007.128736. View

Mjosberg J, Trifari S, Crellin N, Peters C, Van Drunen C, Piet B . Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011; 12(11):1055-62. DOI: 10.1038/ni.2104. View

Gregory L, Jones C, Walker S, Sawant D, Gowers K, Campbell G . IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax. 2012; 68(1):82-90. PMC: 3534261. DOI: 10.1136/thoraxjnl-2012-202003. View

Halim T, Krauss R, Sun A, Takei F . Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity. 2012; 36(3):451-63. DOI: 10.1016/j.immuni.2011.12.020. View

Kearley J, Erjefalt J, Andersson C, Benjamin E, Jones C, Robichaud A . IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med. 2010; 183(7):865-75. PMC: 3385369. DOI: 10.1164/rccm.200909-1462OC. View

Skirrow H, Wincott T, Cecil E, Bottle A, Costelloe C, Saxena S . Preschool respiratory hospital admissions following infant bronchiolitis: a birth cohort study. Arch Dis Child. 2019; 104(7):658-663. DOI: 10.1136/archdischild-2018-316317. View

Jartti T, Lehtinen P, Vuorinen T, Ruuskanen O . Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J. 2009; 28(4):311-7. DOI: 10.1097/INF.0b013e31818ee0c1. View

10.

Smith D, Seales S, Budzik C . Respiratory Syncytial Virus Bronchiolitis in Children. Am Fam Physician. 2017; 95(2):94-99. View

11.

Bellinghausen I, Klostermann B, Knop J, Saloga J . Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol. 2003; 111(4):862-8. DOI: 10.1067/mai.2003.1412. View

12.

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

13.

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13(2):145-9. DOI: 10.1038/nri3365. View

14.

Semple M, Dankert H, Ebrahimi B, Correia J, Booth J, Stewart J . Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P. PLoS One. 2007; 2(10):e1038. PMC: 2001182. DOI: 10.1371/journal.pone.0001038. View

15.

Kim C, Kim S, Park C, Kim B, Kang H, Koh Y . Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol. 2003; 112(1):64-71. DOI: 10.1067/mai.2003.1618. View

16.

Graham B, Johnson T, Peebles R . Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology. 2000; 48(3):237-47. DOI: 10.1016/s0162-3109(00)00233-2. View

17.

El-Gamal Y, Heshmat N, Mahran M, El-Gabbas Z . Expression of the apoptosis inhibitor Bcl-2 in sputum eosinophils from children with acute asthma. Clin Exp Allergy. 2004; 34(11):1701-6. DOI: 10.1111/j.1365-2222.2004.02089.x. View

18.

Mitchell J, Dimov V, Townley R . IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease. Curr Opin Investig Drugs. 2010; 11(5):527-34. View

19.

Hoyler T, Klose C, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins E . The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 2012; 37(4):634-48. PMC: 3662874. DOI: 10.1016/j.immuni.2012.06.020. View

20.

Frassanito A, Fedele G, Leone P, Nenna R, Midulla F, Schiavoni I . Use of a short-term whole blood intracellular staining assay to study the T-cell response in respiratory syncytial virus-infected pediatric patients. J Biol Regul Homeost Agents. 2018; 32(5):1339-1344. View